RE:RE:German Facility Construction Completed"We are pleased to additionally support German patients in the upcoming months with high-quality imported cannabis flower and oils from Denmark and Canada. Aphria Germany also holds a 25.1% interest in Berlin-based Schneberg Hospital, which provides access to both doctors and patients for education on the benefits of medical cannabinoids. CannRelief, a CBD-based nutraceutical and cosmetics product line for the German market, produced in the EU and distributed by CC Pharma, a subsidiary of Aphria Inc. with access to more than 13,000 pharmacies throughout Germany." said Hendrik Knopp, Managing Director of Aphria Germany.